Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Efficacy of Ustekinumab versus Vedolizumab for Ulcerative Colitis: Differences between Short- and Long-Term Outcomes Based on Endoscopic Remission.

Inflammatory intestinal diseases·2026
Same author

Impact of Bowel Rest on Hospitalized Patients with Ulcerative Colitis.

Inflammatory intestinal diseases·2026
Same author

From mice to humans-divergent strategies for intestinal homeostasis and regeneration.

FEBS letters·2026
Same author

Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors.

Nature genetics·2026
Same author

Privacy preserving digital platform for patient reported outcomes in inflammatory bowel disease.

NPJ digital medicine·2026
Same author

Diagnostic performance of indigo carmine-assisted texture and color enhanced magnified imaging for superficial non-ampullary duodenal epithelial tumors.

Therapeutic advances in gastroenterology·2026

Related Experiment Video

Updated: Apr 17, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

3.1K

Intestinal tumor in a dish.

Yuki Ohta1, Toshiro Sato1

  • 1Department of Gastroenterology, Keio University School of Medicine , Tokyo , Japan.

Frontiers in Medicine
|February 24, 2015
PubMed
Summary

Colorectal cancer (CRC) drug response prediction is challenging due to tumor diversity. Patient-derived organoids offer a promising approach to test treatments in vitro, enabling personalized medicine for colorectal cancer.

Area of Science:

  • Oncology
  • Genetics
  • Stem Cell Biology
  • Drug Development

Background:

  • Colorectal cancer (CRC) exhibits significant genetic and epigenetic diversity, complicating prediction of patient response to chemotherapy.
  • Current drug development relies on large clinical trials, which are time-consuming and costly.
  • Genetic stratification improves prediction but often falls short due to cancer genome complexity.

Purpose of the Study:

  • To review the application of organoid culture technology for colorectal cancer (CRC) research.
  • To explore the potential of patient-derived CRC organoids for personalized drug response prediction.
  • To discuss the clinical perspectives of using CRC organoids in treatment selection.

Main Methods:

  • Development of an efficient and tractable organoid culture system for intestinal stem cells.
Keywords:
Wnt proteinscolorectal cancersintestinal stem cellsorganoidspersonalized medicine

More Related Videos

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

36.1K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 17, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

3.1K
In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

36.1K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

2.6K
  • Adaptation of organoid technology for culturing colorectal tumors.
  • Utilizing organoids to recapitulate tumor architecture and monitor patient-specific tumor growth and drug response.

    • Main Results:

    • Organoid cultures successfully recapitulate the original tissue architecture of intestinal stem cells and colorectal tumors.
    • This technology allows for the monitoring of patient-derived tumor growth and response to therapeutic agents in vitro.
    • Organoids provide a viable model for personalized drug screening.

    Conclusions:

    • Organoid culture represents a powerful tool for understanding colorectal cancer heterogeneity.
    • Patient-derived CRC organoids hold significant promise for predicting individual treatment efficacy.
    • This technology offers a pathway towards personalized medicine and optimized treatment strategies for colorectal cancer patients.